Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Patient experience: Living with ovarian cancer

April 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …
Feature
fda2outsideweb

Alkermes sent reeling as FDA refuses review of depression treatment

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma

Alkermes shares were knocked down to their lowest level since October 2016 after it was revealed that the FDA had …
News
medimmune_building_cambridge

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
News
shutterstock_168864905

InSight Innovations to buy CureTech in $550m deal

March 28, 2018 Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …
News
genentechlr_copy

Five deaths linked to Roche’s haemophilia drug Hemlibra

March 28, 2018 Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma

Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …
News

Pfizer seeks tax breaks in return for planned $456m facility

March 28, 2018 Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break

Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city. …
News
theresa_may_-_credit_arno_mikkor

May hints at providing long-term funding plan for NHS

March 28, 2018 Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

After the news broke earlier in the week of a group of nearly 100 MPs calling for a parliamentary commission …
News
brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …
Feature
skin-222664_960_720

New organ discovery has implications for cancer treatment

March 27, 2018 Research and Development biotech, drugs, pharma, pharmaceutical

The discovery of an entirely new organ, the 80th to be discovered in the human body, could have serious implications …
News
headache

Reaction mixed to Biohaven’s migraine drug results

March 27, 2018 Manufacturing and Production, Research and Development Allergan, Biohaven, CGRP, biotech, drugs, migraine, pharma, pharmaceutical

Biohaven is full of confidence in its lead drug, rimegepant, evidenced only a few weeks ago when it decided to …
News
pharmafocus_april_2018_cover

The April 2018 issue of Pharmafocus is now live!

March 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma

As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …
News
ablynx_flags-web

Ablynx’s vobarilizumab trial fails and sees two patient deaths in systemic lupus erythematosus

March 26, 2018 Research and Development, Sales and Marketing AbbVie, Ablynx, Sanofi, Vobarilizumab, pharma, systemic lupus erythematosus

Ablynx has revealed that its interleukin 6 pathway via its IL-6 receptor (IL-6R) vobarilizumab failed to meet its primary endpoint …
News
eu-flag-2108026_960_720

Six reasons why UK pharma has more to gain, than fear, from Brexit

March 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical

There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …
Feature
roche_close

Roche’s Tecentriq improves OS in first-line lung cancer

March 26, 2018 Research and Development, Sales and Marketing Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq

Roche has revealed further data from its Phase 3, IMpower150 study, which showed that a combination of Tecentriq and Avastin, …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026